No Prescription |
 |
 | ||
|
Biduret Moduretic |
|
| ||
No Prescription » Prescription Drugs 3 » Biduret Moduretic Amiloride is used with hydrochlorothiazide to treat high blood pressure (hypertension) certain heart problems (congestive heart failure) or swelling (edema) that may be caused by severe liver problems.Lowering high blood pressure helps prevent strokes heart attacks and kidney problems. Controlling congestive heart failure helps prevent a worsening of the disease and its symptoms such as tiredness difficulty breathing and swelling (edema).This medication contains two drugs amiloride and hydrochlorothiazide. Each medication is a water pill (diuretic) that works by increasing the amount of urine you make allowing your body to get rid of extra salt and water. Amiloride also prevents the kidneys from getting rid of too much potassium. Buy Biduret Moduretic and other Prescription Drugs 3 products online at Medstore. Buy Online at Medstore - Click Here!
About Biduret Moduretic: Product Type: Prescription Drugs 3 Biduret (Moduretic Generic Amiloride/Hydrochlorothiazide) Biduret (Moduretic Generic Amiloride/Hydrochlorothiazide) Moduretic Generic Amiloride/Hydrochlorothiazide 5/50mg 250 Tablets 500(2 x 250) Tablets Moduretic Generic Amiloride/Hydrochlorothiazide Biduret
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
